Publication | Closed Access

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

Type 1Diabetic RetinopathyOcular DiseaseDiabetes ManagementOphthalmologyDiabetesDirect-protect 1Direct-prevent 1Diabetes MellitusMedicine